Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N A Harris

Showing results (51-60 of 200) with videos related to

Pageof 20
Sort By:
Microorganisms|January 21, 2023
Epidemiology of <i>Aeromonas</i> Species Bloodstream Infection in Queensland, Australia: Association with Regional and Climate ZonesHolly A Sinclair, Felicity Edwards, Patrick N A Harris, et al.
Bioinformatics Advances|January 26, 2023
CATHAI: cluster analysis tool for healthcare-associated infectionsThom Cuddihy, Patrick N A Harris, Budi Permana, et al.
Jac-Antimicrobial Resistance|November 10, 2021
Adverse clinical outcomes associated with carbapenem-resistant <i>Acinetobacter</i> (CRA) infections: a systematic review and meta-analysisWeiping Ling, Luis Furuya-Kanamori, Yukiko Ezure, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 4, 2022
Determinants and outcomes of bloodstream infections related to obesityFelicity Edwards, Kate Glen, Patrick N A Harris, et al.
Infectious Diseases (London, England)|March 5, 2025
Community-onset bloodstream infection among people with opioid use disorders: a twenty-year population-based cohort study in Queensland, AustraliaKevin B Laupland, Adam G Stewart, Felicity Edwards, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 2, 2024
Win Ratio Analyses of Piperacillin-Tazobactam Versus Meropenem for Ceftriaxone-Nonsusceptible Escherichia coli or Klebsiella pneumoniae Bloodstream Infections: Post Hoc Insights From the MERINO TrialMelissa Hardy, Patrick N A Harris, David L Paterson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2022
Breaking Down the Breakpoints: Rationale for the 2022 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against EnterobacteralesPranita D Tamma, Patrick N A Harris, Amy J Mathers, et al.
Jac-Antimicrobial Resistance|January 6, 2022
Activity of temocillin against third-generation cephalosporin-resistant <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> bloodstream isolates from a clinical trialAdam G Stewart, Andrew Henderson, Michelle J Bauer, et al.
Microbiology Spectrum|April 25, 2022
Morganella morganii, an Emerging Cause of Bloodstream InfectionsKevin B Laupland, David L Paterson, Felicity Edwards, et al.
Trials|April 23, 2021
Ceftolozane-tazobactam versus meropenem for definitive treatment of bloodstream infection due to extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales ("MERINO-3"): study protocol for a multicentre, open-label randomised non-inferiority trialAdam G Stewart, Patrick N A Harris, Mark D Chatfield, et al.
Pageof 20

Showing results (51-60 of 200) with videos related to

Sort By:
Pageof 20
Microorganisms|January 21, 2023
Epidemiology of <i>Aeromonas</i> Species Bloodstream Infection in Queensland, Australia: Association with Regional and Climate ZonesHolly A Sinclair, Felicity Edwards, Patrick N A Harris, et al.
Bioinformatics Advances|January 26, 2023
CATHAI: cluster analysis tool for healthcare-associated infectionsThom Cuddihy, Patrick N A Harris, Budi Permana, et al.
Jac-Antimicrobial Resistance|November 10, 2021
Adverse clinical outcomes associated with carbapenem-resistant <i>Acinetobacter</i> (CRA) infections: a systematic review and meta-analysisWeiping Ling, Luis Furuya-Kanamori, Yukiko Ezure, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 4, 2022
Determinants and outcomes of bloodstream infections related to obesityFelicity Edwards, Kate Glen, Patrick N A Harris, et al.
Infectious Diseases (London, England)|March 5, 2025
Community-onset bloodstream infection among people with opioid use disorders: a twenty-year population-based cohort study in Queensland, AustraliaKevin B Laupland, Adam G Stewart, Felicity Edwards, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 2, 2024
Win Ratio Analyses of Piperacillin-Tazobactam Versus Meropenem for Ceftriaxone-Nonsusceptible Escherichia coli or Klebsiella pneumoniae Bloodstream Infections: Post Hoc Insights From the MERINO TrialMelissa Hardy, Patrick N A Harris, David L Paterson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2022
Breaking Down the Breakpoints: Rationale for the 2022 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against EnterobacteralesPranita D Tamma, Patrick N A Harris, Amy J Mathers, et al.
Jac-Antimicrobial Resistance|January 6, 2022
Activity of temocillin against third-generation cephalosporin-resistant <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> bloodstream isolates from a clinical trialAdam G Stewart, Andrew Henderson, Michelle J Bauer, et al.
Microbiology Spectrum|April 25, 2022
Morganella morganii, an Emerging Cause of Bloodstream InfectionsKevin B Laupland, David L Paterson, Felicity Edwards, et al.
Trials|April 23, 2021
Ceftolozane-tazobactam versus meropenem for definitive treatment of bloodstream infection due to extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales ("MERINO-3"): study protocol for a multicentre, open-label randomised non-inferiority trialAdam G Stewart, Patrick N A Harris, Mark D Chatfield, et al.
Pageof 20